ArticleCureus2026

Musculoskeletal Adverse Event Signals Associated With Semaglutide, Liraglutide, and Tirzepatide in the US FDA Adverse Event Reporting System.

Akshita Wadhwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.